Current Infectious Disease Society of America guidelines for the treatment of invasive candidiasis recommend a minimum ...

Clinicians in the US may be overprescribing topical antifungal treatments for skin infections, potentially exacerbating a growing problem of drug resistance, according to a new study. Last year, a ...

Mundipharma and CorMedix have unveiled a win for their antifungal drug Rezzayo at preventing invasive fungal diseases in ...

Toenail fungus (the medical term is "onychomycosis") is a very common condition. You can get it from walking around a wet pool deck or locker room, or from sweating in shoes all day. Nail fungi love ...

Antibiotic resistance is a known threat, but a "silent surge" of drug-resistant fungi is the next global health crisis.

Invasive fungal infections are now estimated to affect about 6.5 million people every year around the world, and while many ...

An international group of scientists is calling for antifungal resistance to be included in the 2026 Global Action Plan on ...

While liposomal amphotericin B (L-AmB) is often used to treat patients with breakthrough or refractory invasive aspergillosis, guidelines give triazoles the first-line nod for most patients. In this ...

In the trial, aimed at evaluating the safety and efficacy of once-weekly Rezzayo, the drug demonstrated a profile comparable with standard antimicrobial regimen in reducing the incidence of invasive ...

The discovery of a new preclinical compound with strong antifungal activity against multidrug-resistant pathogens is described in Nature. The drug, named mandimycin, is a member of a known family of ...